Enthera S.r.l.
- Address
- Via Uberto Visconti Di Modrone 18
Sponsor Overview
Specializations
Inflammatory Bowel Disease
Enthera S.r.l. focuses on inflammatory bowel disease, with specific attention to moderate to severe active ulcerative colitis. The clinical research activity is centered on therapies intended for patients with persistent intestinal inflammation and disease burden.
- Ulcerative colitis
- Intestinal inflammation
- Gastrointestinal immune-mediated disease
The sponsor’s research landscape is concentrated on treatment areas relevant to gastroenterology and immune-mediated bowel disorders.
Therapeutic Development
The sponsor is involved in the clinical evaluation of a targeted therapeutic candidate for ulcerative colitis, reflecting interest in disease-modifying approaches for chronic bowel inflammation and related symptoms.
- Novel therapeutic agents
- Disease control in colitis
- Immune-related intestinal disorders
This area highlights a focus on advancing medical options for patients with active inflammatory bowel disease.
Safety and Tolerability
Clinical interest also extends to the safety and tolerability profile of investigational treatment in patients with moderately to severely active ulcerative colitis, supporting the assessment of treatment suitability in a chronic disease setting.
- Patient tolerability
- Therapy safety
- Long-term treatment suitability
These topics are closely tied to clinical care in specialist gastroenterology and immune-mediated disease management.
Pharmacokinetics
The sponsor’s research includes pharmacokinetic evaluation, indicating an interest in how the investigational therapy is processed in the body in the context of ulcerative colitis treatment.
- Drug disposition
- Exposure assessment
- Clinical pharmacology
This supports research activity at the intersection of clinical pharmacology and gastrointestinal therapeutics.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Safety, Tolerability, and Pharmacokinetics of Ent001 in Moderate to Severe Ulcerative Colitis Patients |  Bulgaria Hungary Romania The Netherlands | Not Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 5 sites across their trial portfolio.
Therapeutic Focus
- 1.Digestive System Diseases1 trial280 other sponsors
Partnered Research Centres
5 centres- Address
- Intrarea Tudor Stefan 38-40, 011658 Bucharest
- Address
- Kaszasdulo Utca 5, 1033 Budapest
- Address
- Ulitsa Sinanishko Ezero 11a, 1680 Sofia
- Address
- Bulevard Bilgariya 104, 1404 Sofia
- Address
- Heidelberglaan 100, 3584 CX Utrecht
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Enthera S.r.l..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.